| Tolebrutinib, a Brain-penetrant Bruton s Tyrosine Kinase Inhibitor, for the Modulation of Chronically Inflamed White Matter Lesions in Multiple Sclerosis | 2021-04-15 | 2023-06-15 | |
| A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy | 2021-04-28 | 2023-05-25 | |
| Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis | 2020-06-09 | 2023-02-25 | 2023-10-26 |
| Systems Analyses of the Immune Response to the Seasonal Influenza Vaccine | 2019-10-02 | 2023-01-31 | 2023-10-03 |
| Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM) | 2017-09-21 | 2022-12-20 | 2023-12-14 |
| Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate | 2014-02-07 | 2022-12-17 | |
| Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia | 2010-07-01 | 2022-12-15 | 2023-10-26 |
| Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult Dermatomyositis | 2017-10-05 | 2022-11-04 | 2023-09-29 |
| Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers | 2019-06-05 | 2022-10-31 | 2023-05-24 |
| Mepolizumab in Episodic Angioedema With Eosinophilia | 2021-01-14 | 2022-10-31 | 2023-09-28 |
| Phase II Trial of Combination Immunotherapy in Subjects With Advanced Small Bowel and Colorectal Cancers | 2020-09-22 | 2022-10-25 | 2023-10-11 |
| Pembrolizumab in Relapsed and Refractory Gray-Zone Lymphoma (GZL), Primary Central Nervous System Lymphoma (PCNSL), and Other Extranodal Diffuse Large B-cell Lymphomas | 2018-02-15 | 2022-10-22 | 2023-09-08 |
| Enzalutamide With or Without Vaccine Therapy for Advanced Prostate Cancer | 2013-08-12 | 2022-09-28 | 2023-07-21 |
| Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated With Age-Related Macular Degeneration | 2016-12-14 | 2022-09-28 | 2023-08-31 |
| Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma | 2019-01-09 | 2022-08-15 | 2023-08-11 |
| Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 2017-09-22 | 2022-07-18 | 2023-03-23 |
| Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer | 2016-01-19 | 2022-07-01 | 2023-05-16 |
| The Safety of Administering a Second Dose of a COVID-19 mRNA Vaccine in Individuals Who Experienced a Systemic Allergic Reaction to an Initial Dose | 2021-09-08 | 2022-06-17 | 2023-06-16 |
| Fixed Dose Flavonoid Isoquercetin on Thrombo-Inflammatory Biomarkers in Subjects With Stable Sickle Cell Disease | 2020-11-02 | 2022-06-13 | 2023-06-02 |
| Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers | 2019-11-13 | 2022-05-27 | 2023-02-27 |
| Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib | 2016-04-13 | 2022-05-25 | 2023-05-10 |
| Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC). | 2022-02-15 | 2022-05-11 | 2023-05-12 |
| Xenodiagnosis After Antibiotic Treatment for Lyme Disease | 2015-07-24 | 2022-05-04 | 2024-04-29 |
| A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer | 2010-05-06 | 2022-04-12 | 2023-04-12 |
| VB-111 in Combination With Nivolumab in People With Metastatic Colorectal Cancer (mCRC) | 2020-08-09 | 2022-04-12 | 2023-03-27 |
| Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis B | 2019-02-13 | 2022-03-29 | |
| Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139 | 2015-05-12 | 2022-03-25 | 2022-08-17 |
| Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma | 2012-05-29 | 2022-03-03 | 2022-07-06 |
| CT COMPARE: CT Coronary Angiography to Measure Plaque Reduction | 2016-04-11 | 2022-01-27 | |
| A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer | 2014-01-24 | 2021-12-17 | 2022-12-09 |
| Denosumab Treatment for Fibrous Dysplasia | 2019-06-13 | 2021-11-17 | |
| Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma | 2013-12-12 | 2021-10-14 | 2022-11-18 |
| Cognitive vs. Emotional Psychopharmacological Manipulations of Fear vs. Anxiety | 2014-06-16 | 2021-10-07 | 2022-10-03 |
| A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer | 2015-01-20 | 2021-08-27 | 2022-07-14 |
| Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004 | 2017-04-05 | 2021-08-25 | 2021-11-09 |
| Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas | 2009-10-22 | 2021-08-06 | 2022-08-08 |
| Etidronate for Arterial Calcifications Due to Deficiency in CD73 (ACDC) | 2012-08-20 | 2021-08-06 | 2022-07-13 |
| Avelumab (Bavencio) With IL-15 in Subjects With Clear-Cell Renal Carcinoma | 2020-05-26 | 2021-07-23 | 2022-03-31 |
| Prebiotics and Metformin Improve Gut and Hormones in Type 2 Diabetes in Youth (MIGHTY-fiber) | 2020-03-10 | 2021-07-15 | 2022-06-10 |
| Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma | 2000-06-01 | 2021-06-09 | 2022-11-02 |
| Combining CRLX101, a Nanoparticle Camptothecin, With Enzalutamide in People With Progressive Metastatic Castration Resistant Prostate Cancer Following Prior Enzalutamide Treatment | 2019-03-26 | 2021-05-15 | 2022-05-02 |
| Sunitinib for Advanced Thymus Cancer Following Earlier Treatment | 2012-05-15 | 2021-04-30 | 2022-04-15 |
| Marizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma | 2020-01-22 | 2021-04-30 | 2021-10-08 |
| Sunitinib in Sarcomas of the Central Nervous System | 2019-02-21 | 2021-04-02 | 2022-02-14 |
| Fostamatinib for Hospitalized Adults With COVID-19 | 2020-10-08 | 2021-03-30 | 2022-02-14 |
| ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma | 2018-01-17 | 2021-03-18 | 2021-12-17 |
| A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC) | 2016-07-05 | 2021-02-17 | 2022-02-10 |
| M7824 in Subjects With HPV Associated Malignancies | 2018-02-27 | 2021-02-02 | 2021-12-27 |
| Dexamethasone to Prevent Oral Chronic Graft-versus-Host Disease | 2006-11-24 | 2021-02-01 | 2022-01-20 |
| Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated or Viral Neoantigens in a Patient With Metastatic Cancer Plus the Administration of Pembrolizumab | 2021-01-27 | 2021-01-27 | |